Evidence map›Paper›PMID 34396954›Full record

ArticleeLife2021

HIF1α is required for NK cell metabolic adaptation during virus infection.

Francisco Victorino, Tarin M Bigley, Eugene Park, Cong-Hui Yao, Jeanne Benoit, Li-Ping Yang, Sytse J Piersma, Elvin J Lauron, Rebecca M Davidson, Gary J Patti and 1 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Hypoxic tumor microenvironment: Destroyer of natural killer cell function.Chinese journal of cancer research = Chung-kuo yen cheng yen chiu · 2024
    Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Francisco VictorinoRheumatology Division, Washington University School of Medicine, St. Louis, United States.ORCID 0000-0001-7626-3219
Tarin M BigleyRheumatology Division, Washington University School of Medicine, St. Louis, United States.
Eugene ParkRheumatology Division, Washington University School of Medicine, St. Louis, United States.ORCID 0000-0002-2617-7571
Cong-Hui YaoDepartment of Chemistry, Department of Medicine, Washington University, St. Louis, United States.
Jeanne BenoitDepartment of Biomedical Research, Center for Genes, Environment and Health, National Jewish Health, Denver, United States.
Li-Ping YangRheumatology Division, Washington University School of Medicine, St. Louis, United States.
Sytse J PiersmaRheumatology Division, Washington University School of Medicine, St. Louis, United States.ORCID 0000-0002-5379-3556
Elvin J LauronRheumatology Division, Washington University School of Medicine, St. Louis, United States.
Rebecca M DavidsonDepartment of Biomedical Research, Center for Genes, Environment and Health, National Jewish Health, Denver, United States.
Gary J PattiDepartment of Chemistry, Department of Medicine, Washington University, St. Louis, United States.ORCID 0000-0002-3748-6193
Wayne M YokoyamaRheumatology Division, Washington University School of Medicine, St. Louis, United States.ORCID 0000-0002-0566-7264
National Jewish Health · US

Funding

NATURAL KILLER CELL CONTROL OF MURINE CYTOMEGALOVIRUS INFECTIONR01AI131680 · NIAID · WASHINGTON UNIVERSITY · PI YOKOYAMA, WAYNE M. · 2017 to 2025
$6.0M
Developing Metabolomic Technologies to Advance Environmental Exposure AnalysisR35ES028365 · NIEHS · WASHINGTON UNIVERSITY · PI PATTI, GARY J · 2017 to 2024
$5.9M
Pediatric Infectious Diseases and Immunity Training ProgramT32AI106688 · NIAID · WASHINGTON UNIVERSITY · PI Megan Anne Cooper, DAVID HUNSTAD · 2014 to 2026
$1.9M
NIAID NIH HHS R01 AI131680NIAID NIH HHS T32 AI106688NIEHS NIH HHS R35 ES028365
6 · The paper itself

Abstract

Natural killer (NK) cells are essential for early protection against virus infection and must metabolically adapt to the energy demands of activation. Here, we found upregulation of the metabolic adaptor hypoxia-inducible factor-1α (HIF1α) is a feature of mouse NK cells during murine cytomegalovirus (MCMV) infection in vivo. HIF1α-deficient NK cells failed to control viral load, causing increased morbidity. No defects were found in effector functions of HIF1αKO NK cells; however, their numbers were significantly reduced. Loss of HIF1α did not affect NK cell proliferation during in vivo infection and in vitro cytokine stimulation. Instead, we found that HIF1α-deficient NK cells showed increased expression of the pro-apoptotic protein Bim and glucose metabolism was impaired during cytokine stimulation in vitro. Similarly, during MCMV infection HIF1α-deficient NK cells upregulated Bim and had increased caspase activity. Thus, NK cells require HIF1α-dependent metabolic functions to repress Bim expression and sustain cell numbers for an optimal virus response.

Indexed as

Lymphocyte ActivationAnimalsCell ProliferationCytomegalovirus InfectionsHypoxia-Inducible Factor 1, alpha SubunitKiller Cells, NaturalMiceMuromegalovirusHif1a protein, mouseHypoxia-Inducible Factor 1, alpha SubunitapoptosisHIF1αimmunologyinflammationMCMVmetabolismmouseNK cells

Identifiers

PMID34396954
PMCPMC8382296
OpenAlexW3194238097

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.